Skip to content
Respiratory disorders are major causes of illness and death in the Indigenous population and contribute to high rates of hospitalisation and mortality. (See Box 1for a description of the different kinds of respiratory disorder.) One-third of Indigenous people reported in the 2001 National Health Survey (NHS) that they had a long-term respiratory condition  and respiratory conditions were responsible for more than one-seventh of hospital separations (excluding those for renal dialysis and pregnancy-related conditions) 1. One in 12 of the deaths and one in 10 of the excess deaths of Indigenous people living in Queensland, Western Australia, South Australia, and the Northern Territory in 1997–99 were attributed to respiratory disease  . As with many other disorders afflicting Indigenous people, the high morbidity and mortality from respiratory disorders are related to their poor environmental and socioeconomic conditions, exacerbated, in some cases, by less than optimal medical management.
After providing a broad overview of current levels of mortality and hospitalisation from respiratory disease among Indigenous people, this section will briefly review other information about acute respiratory infections and about chronic respiratory diseases, including asthma2. Readers should refer also to information on pneumococcal disease and on Haemophilus influenza.
The term respiratory disease refers to a number of conditions that affect the lungs or their components; each of these conditions is characterised by some level of impairment of the lungs in performing the essential function of gas exchange. Respiratory disorders, which can be caused by a variety of different factors and other medical problems (which may or may not start in the lungs), are generally divided into two basic categories: acute respiratory infections and chronic respiratory disorders.
Acute respiratory infections (ARIs), usually caused by viral or bacterial organisms, are categorised according to the location of the infection within the respiratory system-namely as upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs)3. All people are affected at some time by ARIs, but children tend to contract them more frequently than adults. The differences in ARI infection rates by age are due largely to the fact that children have little or no prior exposure to the infections (and hence little or no immunity), and to nutritional and hygiene factors. It is estimated that globally 3–3.5 million children under 5 years of age die from ARIs every year.
URTIs are more common than LRTIs, and are usually caused by viruses. Common URTIs include acute nasopharyngitis (common cold), acute sinusitis, acute pharyngitis, and acute tonsillitis. URTIs are generally mild and self-limiting in nature, and result in little or no mortality. In some cases, however, especially those caused by bacteria, URTIs can lead to serious complications. For example, epiglottitis caused by Haemophilus influenzae, if left untreated, can be fatal (see the section on H. influenzae); and acute otitis media (middle-ear infection) caused by S. pneumoniae or H. influenzae can result in hearing loss and subsequent learning and speech impairments. (Because it is such a serious health problem, middle-ear infection, although technically a respiratory infection, is covered separately in the EarInfoNet.)
LRTIs, while less common than URTIs, account for most of the hospitalisation and deaths associated with ARIs. As with URTIs, viruses are responsible for the majority of LRTIs, but the most serious forms are bacterial. LRTIs that can result in hospitalisation and death include pneumonia, bronchopneumonia, acute bronchitis, and bronchiolitis.
The main chronic respiratory conditions are chronic bronchitis, emphysema, asthma, and bronchiectasis. (Asthma is classified as a chronic condition, even though most morbidity is due to acute episodes.)
Chronic bronchitis is diagnosed clinically on the basis of a history of daily coughing with sputum production for at least 3 months of the year for more than 1 year. Obstruction of the airways with mucus may occur (due to inflammation and swelling of airway linings), increasing the likelihood of bacterial lung infections. Emphysema is caused by dilation and destruction of the lung alveoli, which usually leads to shortness of breath. The factors contributing to the development of chronic bronchitis and emphysema are very similar - cigarette smoking is the main factor, but climate and air pollution also contribute.
Asthma is an inflammatory condition of the airways that results in episodes or attacks of breathing problems (such as coughing, wheezing, chest tightness, and shortness of breath). Symptoms arise because inflammation of the airways, which is largely a result of hyper-responsiveness to allergens and irritants (including physical activity and upper respiratory infections), results in airflow obstruction.
Bronchiectasis, generally very uncommon in developed countries like Australia, is permanent dilatation of the bronchi caused by destruction of the elastic and muscular components of the bronchial walls, usually resulting from a previous infectious illness, such as pneumonia. The disease is characterised by recurrent respiratory infections, a disabling cough, breathlessness, and high sputum production.
Chronic obstructive pulmonary disease (COPD), the term applied to chronic disorders for which airway inflammation and airflow limitation are not fully reversible, includes chronic bronchitis, emphysema, bronchiectasis and many cases of asthma.
Disease of the respiratory system was the fourth most common cause of death for Indigenous males living in Queensland, WA, SA, and the NT combined for the period 1997-1999, and was responsible for 8.2% of deaths . It was responsible for 8.5% of deaths of Indigenous females, making it the fifth most common cause of death. Importantly, it was responsible for almost one-tenth of excess deaths experienced by Indigenous people. The more detailed breakdown of deaths for Indigenous people living in WA, SA and the NT for 1999-2001 reveals that the number of Indigenous deaths from respiratory deaths was five times the number expected from rates for the non-Indigenous population (Table 1). The leading specific respiratory cause of death for both Indigenous males and females for this period was chronic lower respiratory disease (J40-J47), for which cause there were around five times more deaths than expected. Pneumonia and influenza (J10-J18) were responsible for only small numbers of deaths, but these numbers were 12-15 times more than expected from rates for the corresponding non-Indigenous populations.
|Category of resiratory disease||Males||Females||Persons|
|Source: Derived from data provided by the AIHW National Mortality Database and ABS low series population projections|
|All respiratory disease (J00-J06)||134||5.2||92||4.5||226||5.0|
|Pneumonia and influenza (J10-J18)||10||12.5||6||15.0||16||13.3|
|Chronic lower respiratory diseases (J40-J47)||66||4.7||15.1||5.0||117||4.8|
|Other respiratory disease||58||5.3||35||3.5||93||4.4|
As well as much higher death rates among infants and very young children, the striking difference between Indigenous and non-Indigenous people in respiratory disease mortality is the very much greater impact among young and middle aged Indigenous people. For all respiratory disease, the death rates for Indigenous people were 9 to 22 times higher than those for non-Indigenous people in the 25-54 years age groups (Table 2).
|Age group (years)||Indigenous||Non-Indigenous||Rate ratios|
|Source: Derived from data provided by the AIHW National Mortality Database and ABS low series population projections|
Respiratory disease was responsible for 15.2% of the 51,880 hospital separations of Indigenous males in Australia in 1999-2000 (excluding those for renal dialysis), and for 14.4% of the 53,351 separations of Indigenous females (excluding those for renal dialysis and pregnancy-related conditions) . Separation rates for respiratory disease were much higher for Indigenous people than for non-Indigenous people - 2.6 times higher for males and 3.2 times higher for females. Indigenous rates were particularly high in infancy and early childhood.
ARIs were responsible for around one-tenth of separations of Indigenous males and for more than one-twelfth of those of Indigenous females (excluding those for renal dialysis and pregnancy-related conditions) (Table 3). The most common specific conditions requiring hospitalisation were those included in the ICD group 'influenza and pneumonia' (J10-J19), with rates for Indigenous males and females 4.6 and 4.9 times respectively those for non-Indigenous males and females. Other acute lower respiratory tract infections (J20-J22) were also much more common causes of hospitalisation for Indigenous people - the rate for Indigenous males was 4.7 times that of non-Indigenous males, and the rate for Indigenous females 5.7 times that of non-Indigenous females. Chronic lower respiratory diseases (J40-J47) were responsible for 3.6% of Indigenous male separations and for 4.4% of Indigenous female separations, with rates 3.0 and 4.1 times respectively those of non-Indigenous males and females.
|Number of separations||Proportion of separations||Rate ratio||Number of separations||Proportion of separations||Rate ratio|
|Source: Lehoczky et al., 2002|
|Influenza and pneumonia||2,417||4.7||4.6||2,114||4.0||4.9|
|Other acute LRTI||1,802||3.5||4.7||1,613||3.0||5.7|
|Other URT conditions||338||0.7||0.4||383||0.7||304|
|Chronic LR diseases||1,879||3.6||3.0||2,322||4.4||4.1|
|Other respiratory diseases||397||0.8||1.9||281||0.5||2.6|
|All respiratory diseases||7,880||15.2||2.6||7,669||14.4||3.2|
|All separations excl dialysis and pregnancy-related separations||51,880||100.0||53,351||100.0|
Information on the incidence of ARI among Indigenous children is scarce, but longitudinal data on 66 Aboriginal children living in remote areas of the NT found that there was an average of five episodes of respiratory illness necessitating clinic attendance during the first year of life .
Prevalence figures may be less sensitive than incidence in measuring the true level of disease in a community, but they do provide an indication of the disease load carried by the population at a given point of time. Unfortunately, prevalence data on ARI among Indigenous children are scarce also - and dated - but they point to the widespread prevalence of serious ARI in some Indigenous communities. In one study in 1979 of seven Aboriginal communities in the Pilbara region of Western Australia, 29% of the population had signs of LRTI, with a quarter of children under 5 years of age affected . From about the same time, a retrospective survey of all infants born during the period 1979-1981 in the Bourke district of New South Wales revealed a 25% prevalence of lobar pneumonia in Indigenous children under the age of 3 years, compared with a 3% prevalence in non-Indigenous children . Further, in one remote Aboriginal community in the north-west Kimberley region of Western Australia, over one-fifth (21%) of children had evidence of lower respiratory infection .
As noted above, ARIs are responsible for a large proportion of the hospitalisation of Indigenous people, but the Australia-wide figures do not reveal the true extent of the differences between Indigenous and non-Indigenous people in hospitalisation rates.
The estimates for Indigenous people living in WA in 1988-1993 are likely to provide a much better indication of the differences between Indigenous and non-Indigenous people. Indigenous infants were hospitalised for acute bronchitis and bronchiolitis at a combined rate of 15,025 admissions per 100,000 person-years, 6.3 times the rate for non-Indigenous infants (Table 4)  . For pneumonia, the rate of 6,189 per 100,000 person-years for Indigenous infants was almost 28 times higher than the non-Indigenous rate. Pneumonia was the main respiratory cause of admissions in the age groups 15-24, 25-39 and 40-54 years, and the second leading cause in adults aged 55 years or older. In general, rates of admission for pneumonia were higher in non-metropolitan than metropolitan areas. The hospitalisation rates vary with age, but the Indigenous:non-Indigenous rate ratios are high across all age groups, particularly for pneumonia.
|Age group (years)||Acute bronchitis and bronchiolitis||Pneumonia|
|Separation rate||Rate ratio||Separation rate||Rate ratio|
|Source: Adapted from (Health Department of Western Australia Office of Aboriginal Health, 1997)
A slightly different insight into hospitalisation information is provided by an innovative Western Australian study using linked antenatal, birth, death and hospital discharge records for all children born in the State from 1980 onwards . For children born in 1986 with birth weights of at least 500 grams, 17% of Indigenous children were hospitalised once and 11% repeatedly for lower respiratory tract illnesses in their first two years of life, compared with 5% and 1% of non-Indigenous children. Pneumonia was the most common reason for respiratory admissions of Indigenous children, and perinatal conditions (such as respiratory distress syndrome and broncho-pulmonary dysplasia) were the most common reasons for admission of non-Indigenous children.
A longitudinal study of 2,254 Indigenous children born during the ten-year period 1976-1985 in the NT also revealed high rates of admission for respiratory tract infections. Of a total of 3,657 hospital admissions, 17% were due to respiratory tract infections . On average, there were six hospital admissions for respiratory tract infections annually for every 100 Indigenous children under five years of age. Since many Indigenous children are diagnosed and treated for ARI at the community level by primary health care services, these hospitalisation rates markedly underestimate the overall incidence of ARI in Indigenous children . An earlier report on hospitalisation for radiologically proven pneumonia in Alice Springs Hospital in 1983 found that admissions of Indigenous children admissions exceeded those of non-Indigenous children by a ratio of more than 60:1 . Figures from Queensland are suggestive also of the high rates of admission for respiratory tract infections in the Indigenous population (even though Indigenous people were not identified separately in hospitalisation data). The separation rate for ARIs (excluding pneumonia) for people living in five Statistical Local Areas (SLAs) for which the Indigenous proportion of the population exceeded 73% was 852 per 100,000 person-years in 1994-1995, compared with 315 per 100,000 for Queensland as a whole . For pneumonia, the admission rate for people living in the five SLAs was 1,354 per 100,000 person-years, a rate 4.6 times higher than for Queensland as a whole.
Indigenous mortality from ARI has fallen significantly over the last few decades, but it still remains an important cause of death at a rate several times higher than that of the non-Indigenous population. As noted above, conditions included in the ICD group 'pneumonia and influenza' were responsible for only small numbers of deaths in WA, SA and the NT in 1999-2001, but the numbers of deaths were much higher than expected.
Mortality from ARI in Indigenous children is low compared with levels in developing countries, but it is still an important cause of Indigenous infant mortality. The published ABS figures do not include an age breakdown of deaths from pneumonia, but mortality from respiratory disease was very high in the infant age group . The death rate for Indigenous male infants was 234 per 100,000, 15.6 times the rate for the total Australian population, and that for Indigenous female infants 247 per 100,000, 19 times higher than the corresponding all Australian rate.
An analysis of the 1991-1996 mortality database for WA, SA and the NT found that there were 22 deaths from acute respiratory infections (including pneumonia and influenza) among children aged 0-9 years . Of these, 9 deaths (41%) were of Indigenous children. The relatively low mortality from ARI in Indigenous children, compared with the situation in developing countries, has been achieved at the cost of an extraordinarily high rate of hospitalisation .
Studies of the aetiology of childhood pneumonia in developing countries (using both invasive procedures, such as lung aspiration, and less invasive procedures, such as blood cultures and serology) have consistently shown Streptococcus pneumoniae (pneumococcus) and Haemophilus influenzae (type b) to be the leading bacterial causes, and respiratory syncytial virus the leading viral cause .
In the first study of its kind to describe the aetiology of acute lower respiratory tract infections in Indigenous children, 322 cases in 280 children admitted to the Alice Springs Hospital in 1990-1992 were analysed prospectively . At least one bacterial, viral or chlamydial agent was found in blood, urine and nasopharyngeal aspirate samples in over two-thirds of the cases (68%). A significant aspect was the high proportion of co-infections - in the 92 cases with serological evidence of pneumococcal infection, there was also evidence of concomitant viral infection in 26 cases, Hib infection in two and chlamydia in two.
A large proportion of the LRTI cases were due to Streptococcus pneumoniae, with at least a third of the cases showing evidence of infection. The identification of pneumococci was mainly determined by the presence of pneumolysin immune complex and antibody assays, as there were only six blood cultures positive for Streptococcus pneumoniae. Of the 20 blood cultures positive for bacteria, 11 were due to Haemophilus influenzae (all except one were type b). The low bacterial isolation rate, particularly for H. influenzae, could well have been due to the fact that a high proportion of cases had a history of antibiotic administration prior to admission. Further, Hib vaccination had started in the area during the latter phase of the study. Evidence of viral infection was present in 155 of the 322 cases (48%). Respiratory syncytial virus was the most common, accounting for one-third of all viral isolates. Other viruses commonly isolated were adenovirus, rhinovirus and parainfluenzae 3.
Chlamydia was detected infrequently, with only two definite and seven possible cases of Chlamydia trachomatis and three cases of Chlamydia pneumoniae. Interestingly, cases of Chlamydia trachomatis LRTI usually had C. trachomatis conjunctivitis as well. This raised the possibility that contamination of nasal secretions from ocular infection via the naso-lacrimal duct may be widespread in this population of Indigenous children in whom trachoma was endemic. If this is the case, horizontal transmission between children with profuse nasal secretions colonised by C. trachomatis is a possibility.
In an analysis of the records of 189 consecutive admissions to Cairns Hospital in 1992-1993 for community-acquired pneumonia (90 of which were Indigenous), S. pneumoniae and H. influenzae were the most common pathogens identified . Indigenous patients also had staphylococcal and melioidosis pneumonia, two types not found in the non-Indigenous patients with pneumonia.
Age is another important factor in LRTI, with almost one-half (47%) of the cases in the Alice Springs study (range: 2 months to 12 years) being under 1 year of age, and 94% under 5 years . The weight-for-height of 10% of the cases was below the third percentile, indicating nutritional wasting. Among Indigenous adults, common risk factors for pneumonia are heavy alcohol use, chronic lung disease and diabetes mellitus .
Melioidosis, or infection with the organism Burkholderia pseudomallei, is being recognised with increasing frequency in northern Australia as a cause of serious morbidity and mortality . The organism is widely distributed in the water and soil of the tropics, and during the rainy season and spreads through direct contact, cutaneous inoculation, inhalation or ingestion . Diabetes and renal failure predispose to clinical disease.
In the period 1990-1998, melioidosis was the second most common cause of admission for, and the most common cause for death from, community-acquired bacteraemic pneumonia at the Royal Darwin Hospital . Pneumonia was the most common form of presentation of the 240 cases of melioidosis recorded in the Top End of the Northern Territory in that period. The severe septicaemic form of pneumonia had a case-fatality rate of over 50%. Information about the breakdown of the cases by Indigenous status is not available, but a detailed analysis of 33 cases early in this nine-year period found that the incidence among Indigenous people was around nine times that among non-Indigenous people . Such a difference is consistent with the believed mode of infection - with most cases believed to be acquired through percutaneous inoculation - and the known risk factors - diabetes, excessive alcohol consumption, chronic renal disease, chronic lung disease and excessive kava consumption .
Based on an analysis of records from the Thursday Island Hospital, all of the 23 cases of melioidosis diagnosed in the Torres Strait in the six-year period 1995-2000 were Torres Strait Islanders . The average annual incidence of 43 cases per 100,000 is the highest documented to date in the Torres Strait area, and considerably higher than the overall incidence of 17 per 100,000 in the Top End of the NT . Most people presented with community-acquired pneumonia or a deep-seated abscess, and five died. More than three-quarters of the people diagnosed with melioidosis were diabetics .
Broad-ranging environmental changes can bring about a reduction in ARI (as well as other infectious diseases) among Indigenous populations. These changes include improvements in housing, waste disposal, and water and power supply . As well, there needs to be an emphasis on strategies promoting optimal growth and protecting infants from ARI. Strategies include antenatal care, breast-feeding, improved weaning practices, frequent washing of hands and faces, childhood immunisation and cessation of parental smoking (view HealthInfoNet tobacco use page).
Improved case management by primary health care providers would contribute also to reducing the high hospitalisation rates from ARI . This would involve allocation of resources, development of appropriate curriculum and standard treatment protocols, training, supervision and evaluation. Immunisation with the pneumococcal vaccine provides the most immediate and effective means of preventing serious morbidity and mortality from pneumococcal disease among Indigenous people. Prevention of melioidosis is possible through health education aimed at high risk groups avoiding contact with wet-season soils or muddy water by using footwear and gloves . Treatment with the appropriate antibiotics is effective, especially if the disease is diagnosed early. Prevention of much of the morbidity and mortality from ARI is achievable, given existing knowledge and technology. But, as with many other areas of Indigenous health, this will require greater political and administrative commitment than shown to date.
After adjusting for differences in the age structures of the two populations, 33% of Indigenous people reported to the 2001 National Health Survey that they had a long-term respiratory condition, compared with 30% of non-Indigenous people (Table 5) . Asthma was the specific respiratory condition most commonly reported by both Indigenous people (17%) and non-Indigenous people (12%). Asthma was reported more frequently by Indigenous people than by non-Indigenous people for every age group. Indigenous people living in remote areas reported having asthma slightly less frequently (15%) than did those living in urban and rural areas (18%).
|Age group (years)||Asthma||Bronchitis||Other respiratory conditions||Any respiratory condition||Asthma||Bronchitis||Other respiratory conditions||Any respiratory condition|
|Source: Australian Bureau of Statistics, 2002
There is virtually no detailed information on the prevalence or extent of chronic bronchitis and emphysema in the Indigenous population, but it is likely to be very high because of the high prevalence of smoking in the population
(view HealthInfoNet tobacco use page). As noted above, the numbers of deaths from chronic lower respiratory diseases for Indigenous people living in WA, SA and the NT in 1999-2001 were around five times the numbers expected from the age-specific rates of the non-Indigenous populations of those jurisdictions. In the five Statistical Location Areas (SLAs) in north Queensland where Indigenous people make up 74% of the population, mortality rates for chronic obstructive pulmonary disease (COPD) (excluding asthma) were 5 times higher than the overall Queensland rates . Australia-wide in 1999-2000, separation rates for these diseases among Indigenous people were 3-4 times those of other Australians . A detailed analysis of hospitalisation in WA in 1988-1993 attributed the much higher separation rates of Indigenous people than of non-Indigenous people for bronchitis (ICD9 490-491), chronic airways obstruction (ICD9 496) and bronchiectasis (ICD9 494) to the cumulative effect over time of exposure to cigarette smoking (Table 6) .
|Separation rates||Rate ratios|
|Age group (years)||Bronchitis||CAO||Bronchiectasis||Bronchitis||CAO||Bronchiectasis||Bronchitis||CAO||Bronchiectasis|
|Source: Adapted from (Williams, et al., 1997)
Bronchiectasis among central Australian Aboriginal children was the subject of considerable interest in the late 1960s and early 1970s, when the disease was identified from clinical records in 83 out of around 1,000 children . Diagnosis was by bronchography in 75% of cases, by bronchoscopy in 10%, and by x-ray and zonal tomography in the remainder. Around two-fifths of the patients underwent lung surgery for their condition. The condition was attributed to bronchiolitis in 47% of cases, pneumonia in 37%, and recurrent unspecified chest infection in the remainder. Cystic fibrosis, the most common cause of bronchiectasis in children in developed countries, was absent as a cause of the disease. Over one-half of the cases had concurrent diarrhoea with dehydration requiring intravenous hydration. Malnutrition was common with two-thirds (67%) being less than the tenth percentile for weight and 57% for height.
A recent study has confirmed that bronchiectasis and clinical chronic suppurative lung disease (CSLD) are still major problems for Indigenous children in the region, with a prevalence of 1.5% among children aged 15 years or younger . Using HRCT (high resolution computed tomography), the current 'gold standard' for confirming bronchiectasis, the study identified 59 children with the disease, only 21 of whom were known cases, and a further six with CSLD (cases in which the strict criteria for diagnosing bronchiectasis were not confirmed by HRCT).
The median age at diagnosis for children with bronchiectasis was 4.8 years and 6.2 years for those with CSLD . Almost 95% of the children with bronchiectasis and 83% of those with CSLD had had at least one previous admission for pneumonia, with a median age of 6 months for the first admission. Slightly less than one-half of the children with bronchiectasis and 17% of those with CSLD had had at least one previous admission for bronchiolitis, with a median age of 5 months for the first admission. Almost three-quarters of all the children had a history of chronic suppurative otitis media (CSOM). In view of the association of CSOM with bacterial colonisation at young ages, the authors suggest that early bacterial pneumonia with incomplete eradication of bacteria and persistent airway inflammation may promote the development of bronchiectasis and CSLD.
The confirmation of persisting high levels of bronchiectasis and CSLD among Indigenous children in central Australia promoted the development by the Working Group on Indigenous Paediatric Respiratory Health of consensus recommendations for their early detection and effective management . The recommendations emphasised the importance of early diagnosis of bronchiectasis and CSLD, and aggressive medical management to reduce morbidity and preserve lung function. The Working Group emphasised also the need to reduce exposure of affected children to wood and tobacco smoke, and for 'a culture-and expertise-appropriate healthcare delivery model'.
Hospital statistics from WA during the period 1988-1993 do not mention bronchiectasis as a significant diagnostic category in children aged under 14 years, but it is a cause of considerable numbers of admissions in older age groups . Admission rates for Indigenous people in the 15-24 years, 25-39 years, 40-54 years and the 55 years and older age groups were respectively 5.6, 6.2, 9.1 and 3.9 times higher than the corresponding non-Indigenous rates.
As noted above, 15% of Indigenous people living in remote areas and 18% of those living in rural and remote areas reported to the 2001 NHS having asthma as long-term health condition . Despite the similarity of these estimates of the proportions of Indigenous people having asthma as a long-term health condition, there is some evidence that the difference in prevalence between remote and other areas may be greater than that reported to the 2001 NHS.
Bearing in mind that its findings having been questioned on methodological grounds  , a study in the early 1990s of 1,252 residents aged 5 to 84 years from two rural Aboriginal communities in Cape York, Queensland and two in central Australia found no self-reported recent wheeze among children 5-7 years of age, and a prevalence of 0.5% in children aged 8-12 years . The prevalence among adults aged 20-84 years was 3.3%.
These estimates differ markedly from those of a more recent study of five communities in the Torres Strait and neighbouring areas of Cape York . In this study, undertaken in 1999, 21% of 1,650 children aged 0-17 years reported ever wheezing, 12% of having wheezed in the previous 12 months, and 16% as having asthma.
Much lower levels of asthma, but high levels of current wheezing, were reported from a small 1993 study in a remote Indigenous community in the far north of WA . Only 5.4% of males and 8.9% of females aged 5 to 18 years reported ever having asthma. On the other hand, 14% of males and 24% of females reported current wheezing. For participants aged 18 years or older, a history of ever being diagnosed with asthma was found for 8.5% of males and 15% of females. Current wheezing was reported by 22% of males and 27% of females.
Somewhat higher levels of asthma were found among children aged 5 to 18 years in a 1999 study in a remote Indigenous community in the far north of WA: 17% among males and 12% among females . In a parallel assessment of a very small number of children living in a community in the central desert area of WA, none of the 10 females studied reported a history of asthma and only 7% among the 14 males did so.
These levels contrast markedly with those documented in a study of 158 Indigenous and 1,341 non-Indigenous children attending primary schools in rural NSW in 1997 . The proportions of Indigenous and non-Indigenous children who had been diagnosed with asthma were the same at 39%. Almost one-third of Indigenous children and 27% of non-Indigenous children reported having wheezed in the previous 12 months.
The relatively low levels for Indigenous children living in remote areas are reflected in hospitalisation figures for the NT. A retrospective review of admissions to the Royal Darwin Hospital for the period 1991-1997 found that the hospitalisation rate for asthma for children aged 1-9 years was 2.6 per 1,000 population for Indigenous children from rural areas, 4.7 for Indigenous children from urban areas, and 5.5 for non-Indigenous children . The contribution of asthma to the overall burden of disease was far less among Indigenous than non-Indigenous children: 6.5% of Indigenous admissions were due to asthma compared with 12.7% of non-Indigenous admissions.
Admission rates for asthma in WA in 1988-1993 were much higher than those for the NT, with those for Indigenous children being particularly high (Table 7) . The age-standardised separation rate for asthma was 3.1 times higher for Indigenous than non-Indigenous people. Separation rates were consistently higher for Indigenous people living in non-metropolitan areas than in the metropolitan area, but the extent to which this reflects differing admission practices is not clear.
|Age group (years)||Separation rate||Rate ratio|
|Source: Adapted from (Williams, et al., 1997)
The variations in the prevalence of asthma among different Indigenous communities and population sub-groups could be due, at least partly, to environmental factors. Allergic stimulants are two main factors involved in the aetiology of asthma, through the development of atopy (involving the production of antibodies in response to an allergic challenge) and airway hyper-responsiveness (AHR)  .
The prevalence of atopy was low to a range of allergens tested among the Indigenous children living in two Cape York and two central Australian communities, for which very low levels of asthma were reported (see above). The prevalence of adult atopy was similar to that found in non-Indigenous people .
Interestingly, the environmental levels of a common asthma allergen, house dust mite, was high in the two Cape York communities and low in the two central Australian communities, but the prevalence of atopy was similar across all communities . The investigators suggest that this could be due to cross-antigenicity between house dust mite allergens and Sarcoptes scabiei (the scabies mite) which is endemic in many Indigenous communities.
Several hypotheses have been put forward to explain the slow acquisition of atopy and the low prevalence of asthma in these Indigenous children. First, the high prevalence of chronic and profuse nasal discharge may prevent or attenuate the presentation of air allergens to the respiratory mucosal surface and thus retard sensitisation to allergens . Second, the high antigen load from recurrent infections may saturate cell-mediated immune response mechanisms and prevent or delay the sensitisation process . Third, given that immune responses to helminthic parasites and to air allergens are virtually identical, the chronic and high levels of intestinal parasites in some Indigenous children may result in a diversion of immune system responses away from interactions with air allergens that are likely to cause asthma .
There is no doubt that asthma has become a major problem for many Indigenous people, but much is still unknown about actual levels and, more importantly, about those aspects that could be addressed in reducing its prevalence and in the management of established cases. For further research to be informative, it has been suggested that measurable factors need to be assessed if the differences between remote, rural and urban communities are to examined properly . As well, the recording of parent-reported levels of asthma and symptoms needs to be accompanied by detailed study of microbial burdens. These aspects could be best combined in prospective cohort studies, which, by providing reliable data about Indigenous children, could benefit their management at the same time as well as contributing to a better understanding of the origins of asthma.
The factors contributing to chronic respiratory disease that are most amenable to interventions for Indigenous people are smoking (view HealthInfoNet tobacco use page), sub-standard/overcrowded housing (view HealthInfoNet environmental health page)and poor nutrition (view HealthInfoNet nutrition page). It is, of course, vital that established respiratory conditions among Indigenous people are diagnosed and managed to the same high standards as experienced by other Australians. This applies to chronic bronchitis, emphysema and bronchiectasis - conditions that have been long recognised as causing considerable morbidity and mortality among Indigenous people - and also to asthma, which appears to be a cause of increasing morbidity.
© Australian Indigenous HealthInfoNet 2013
This product, excluding the Australian Indigenous HealthInfoNet logo, artwork, and any material owned by a third party or protected by a trademark, has been released under a Creative Commons BY-NC-ND 3.0 (CC BY-NC-ND 3.0) licence. Excluded material owned by third parties may include, for example, design and layout, images obtained under licence from third parties and signatures.